IGNITE Blend – The Metabolic Cutting Stack

IGNITE is the cutting stack for people who want to stay off the growth-hormone axis. NAD+, MOTS-c and 5-Amino-1MQ in one vial — three compounds that work the mitochondria and the NAD pathway directly, with no growth-hormone signaling at all. The metabolic counterpart to SHRED. 🔥 IGNITE Blend — The Metabolic Cutting Stack Fat loss from inside the cell, not from the pituitary. What it is, in plain English Most cutting stacks lean on growth hormone — prompting the pituitary to release more of it, or borrowing a fragment of the molecule. IGNITE takes a different road entirely. It works the machinery inside the cell that decides whether fuel gets burned. NAD+ is the coenzyme every cell uses to turn food into energy, and levels fall steadily with age. 5-Amino-1MQ blocks an enzyme that quietly drains that NAD+ supply in fat tissue, so more of it stays available. MOTS-c is a peptide the mitochondria themselves produce, and it behaves like an exercise signal — switching on the pathways that burn fuel rather than store it. Three compounds, one target: the mitochondria. How it helps 🔥 A cutting stack with no growth-hormone signaling ⚡ NAD+ and 5-Amino-1MQ work the same pathway from both ends 🏃 MOTS-c targets mitochondrial fuel use directly 🧪 Three compounds in one vial — one draw, one injection Why people reach for it Some people want a body-composition stack but cannot, or would rather not, run a growth-hormone protocol — a personal history of cancer, blood-sugar concerns, or simply a preference to leave that axis alone. SHRED is closed to them. IGNITE is built for exactly that person. It also sits naturally alongside a GLP-1: the GLP-1 handles appetite, IGNITE handles what happens to the fuel. SHRED Blend IGNITE Blend Approach Growth-hormone axis Mitochondrial / NAD pathway Contains AOD-9604, CJC-1295, Ipamorelin, MOTS-c NAD+, MOTS-c, 5-Amino-1MQ Shared compound MOTS-c MOTS-c Growth-hormone signaling Yes None Is it a fit? IGNITE suits someone focused on body composition who wants to stay off the growth-hormone axis, or who has been told to. Anyone comfortable with a GH-axis protocol and chasing lean mass as well as fat loss may find SHRED the stronger lever. Anyone whose main obstacle is appetite should look at the GLP-1 range first. Take the 60-second peptide quiz or message our team, and our providers can point the way. 🔬 For the science-minded NAD+ (nicotinamide adenine dinucleotide) is the central redox coenzyme of cellular energy metabolism and a substrate for the sirtuin and PARP enzyme families; tissue levels decline with age. 5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT); blocking NNMT spares nicotinamide for NAD+ synthesis via the salvage pathway and has been associated with reduced adipose mass in animal models. MOTS-c is a mitochondrial-derived peptide encoded in the 12S rRNA region of mitochondrial DNA, reported to activate AMPK and improve metabolic flexibility. None of the three acts on the growth-hormone / IGF-1 axis. Human trial data remain limited for 5-Amino-1MQ and MOTS-c. This is not a growth-hormone-axis protocol. It carries none of the blood-sugar or cancer-history cautions that apply to SHRED, TITAN or the CJC / Ipamorelin stacks. Educational only — not medical advice. Peptides discussed here are research compounds; whether any is appropriate is a decision between a patient and their licensed provider.